Winton Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,056
Closed -$1.16M 1331
2026
Q1
$1.16M Buy
2,056
+587
+40% +$376K 0.04% 505
2025
Q4
$994K Sell
1,469
-620
-30% -$422K 0.03% 487
2025
Q3
$1.33M Buy
+2,089
New +$1.27M 0.05% 336
2025
Q2
Sell
-8,314
Closed -$3.49M 902
2025
Q1
$3.49M Sell
8,314
-7,186
-46% -$3.12M 0.21% 113
2024
Q4
$6.41M Buy
+15,500
New +$6.8M 0.43% 50
2024
Q3
Sell
-1,260
Closed -$614K 704
2024
Q2
$614K Sell
1,260
-94
-7% -$47.2K 0.04% 397
2024
Q1
$731K Buy
+1,354
New +$740K 0.05% 404
2023
Q4
Sell
-937
Closed -$410K 793
2023
Q3
$410K Sell
937
-47
-5% -$23.4K 0.03% 344
2023
Q2
$494K Buy
+984
New +$472K 0.04% 322
2022
Q1
Sell
-576
Closed -$379K 1052
2021
Q4
$379K Sell
576
-2,896
-83% -$1.82M 0.02% 759
2021
Q3
$2.16M Buy
3,472
+1,700
+96% +$1.14M 0.12% 162
2021
Q2
$1.12M Sell
1,772
-181
-9% -$99.9K 0.06% 466
2021
Q1
$956K Sell
1,953
-358
-15% -$179K 0.05% 491
2020
Q4
$1.16M Sell
2,311
-5,754
-71% -$2.57M 0.08% 337
2020
Q3
$3.17M Sell
8,065
-6,003
-43% -$2.22M 0.1% 305
2020
Q2
$4.64M Sell
14,068
-869
-6% -$252K 0.12% 245
2020
Q1
$3.62M Sell
14,937
-19,593
-57% -$5.11M 0.1% 374
2019
Q4
$9.02M Buy
34,530
+4,452
+15% +$1.17M 0.13% 272
2019
Q3
$8.18M Buy
30,078
+25,068
+500% +$6.98M 0.1% 257
2019
Q2
$1.38M Buy
5,010
+852
+20% +$210K 0.03% 341
2019
Q1
$930K Sell
4,158
-2,066
-33% -$426K 0.02% 361
2018
Q4
$1.16M Buy
6,224
+774
+14% +$159K 0.02% 329
2018
Q3
$1.36M Buy
5,450
+320
+6% +$77.7K 0.03% 350
2018
Q2
$1.12M Sell
5,130
-6,676
-57% -$1.38M 0.03% 404
2018
Q1
$2.26M Sell
11,806
-6,211
-34% -$1.15M 0.06% 311
2017
Q4
$2.82M Sell
18,017
-6,036
-25% -$950K 0.08% 343
2017
Q3
$3.74M Buy
24,053
+20,772
+633% +$3.28M 0.12% 199
2017
Q2
$530K Sell
3,281
-572
-15% -$92.9K 0.02% 493
2017
Q1
$596K Buy
+3,853
New +$531K 0.02% 359
2016
Q4
Sell
-172,391
Closed -$19.4M 465
2016
Q3
$19.4M Buy
172,391
+1,717
+1% +$181K 0.33% 115
2016
Q2
$15.8M Buy
+170,674
New +$14.7M 0.26% 147
2015
Q4
Sell
-210,210
Closed -$15.6M 337
2015
Q3
$15.6M Buy
210,210
+168,644
+406% +$12.1M 0.12% 262
2015
Q2
$2.67M Sell
41,566
-124,264
-75% -$8.6M 0.02% 337
2015
Q1
$12.8M Sell
165,830
-56,864
-26% -$4.43M 0.1% 271
2014
Q4
$16.5M Sell
222,694
-101,798
-31% -$7.14M 0.2% 189
2014
Q3
$19.1M Sell
324,492
-97,854
-23% -$6.19M 0.14% 261
2014
Q2
$28.2M Buy
+422,346
New +$26.9M 0.19% 219

Other funds holding IDXX

Winton Group's IDXX Position: Q2 2026 in Review

Winton Group sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 2,056 shares — an estimated $1.16M sold.

Winton Group first reported a position in IDXX in Q2 2014 and held it in 37 quarters. The position peaked at $28.2M in Q2 2014. 1,046 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Winton Group reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Winton Group sold 2,056 Idexx Laboratories shares in Q2 2026, an estimated $1.16M.
  • Winton Group first reported a position in Idexx Laboratories in Q2 2014 and held it in 37 quarters.
  • Winton Group's Idexx Laboratories position peaked at $28.2M in Q2 2014.
  • 1,046 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.